SAR-405838

Star0

DB12541InvestigationalSmall molecule

SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.

Formula / weight: C₂₉H₃₄Cl₂FN₃O₃ · 562.51 g/mol (avg)
Code names: MI-77301 · SAR405838

Resolves to

Compound

UNII8570LZ3RCACAS1303607-60-4ChEMBLCHEMBL2381408PubChem53476877

Structure

InChIKeyIDKAKZRYYDCJDU-HBMMIIHUSA-NSMILESCC(C)(C)C[C@@H]1N[C@H]([C@H](C2=C(F)C(Cl)=CC=C2)[C@]11C(=O)NC2=C1C=CC(Cl)=C2)C(=O)N[C@H]1CC[C@H](O)CC1

Targets

P04637TP53

Transporters

P08183ABCB1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with SAR-405838, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account